Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 33 studies | 42% ± 16% | |
fibroblast | 29 studies | 30% ± 11% | |
smooth muscle cell | 29 studies | 47% ± 15% | |
endothelial cell | 15 studies | 30% ± 13% | |
myofibroblast cell | 13 studies | 38% ± 14% | |
connective tissue cell | 10 studies | 27% ± 11% | |
adipocyte | 8 studies | 43% ± 11% | |
epithelial cell | 7 studies | 28% ± 14% | |
classical monocyte | 6 studies | 27% ± 7% | |
dendritic cell | 6 studies | 28% ± 10% | |
astrocyte | 6 studies | 33% ± 15% | |
cardiac muscle cell | 5 studies | 67% ± 8% | |
basal cell | 5 studies | 23% ± 11% | |
type I pneumocyte | 5 studies | 22% ± 8% | |
type II pneumocyte | 5 studies | 30% ± 5% | |
myeloid cell | 4 studies | 26% ± 5% | |
ciliated cell | 4 studies | 27% ± 7% | |
abnormal cell | 4 studies | 24% ± 9% | |
conventional dendritic cell | 3 studies | 38% ± 10% | |
mononuclear phagocyte | 3 studies | 24% ± 10% | |
muscle cell | 3 studies | 65% ± 17% | |
glutamatergic neuron | 3 studies | 27% ± 8% | |
ependymal cell | 3 studies | 29% ± 18% | |
macrophage | 3 studies | 28% ± 12% | |
monocyte | 3 studies | 27% ± 4% | |
transit amplifying cell | 3 studies | 34% ± 19% | |
GABAergic neuron | 3 studies | 27% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 99% | 6617.71 | 456 / 459 | 98% | 19.10 | 1101 / 1118 |
uterus | 99% | 13716.12 | 169 / 170 | 98% | 19.99 | 448 / 459 |
lung | 96% | 5019.49 | 556 / 578 | 99% | 17.26 | 1147 / 1155 |
ovary | 100% | 9747.39 | 180 / 180 | 94% | 10.43 | 405 / 430 |
bladder | 100% | 19095.48 | 21 / 21 | 89% | 13.89 | 447 / 504 |
prostate | 89% | 6308.67 | 218 / 245 | 99% | 18.97 | 496 / 502 |
esophagus | 82% | 19261.98 | 1183 / 1445 | 100% | 25.87 | 183 / 183 |
intestine | 81% | 14823.03 | 782 / 966 | 99% | 22.12 | 523 / 527 |
thymus | 81% | 3314.66 | 532 / 653 | 96% | 14.17 | 583 / 605 |
skin | 86% | 4951.67 | 1547 / 1809 | 72% | 6.71 | 340 / 472 |
stomach | 48% | 9297.70 | 174 / 359 | 100% | 25.88 | 285 / 286 |
adrenal gland | 58% | 2135.24 | 149 / 258 | 65% | 4.91 | 149 / 230 |
liver | 11% | 333.12 | 24 / 226 | 90% | 9.27 | 364 / 406 |
blood vessel | 100% | 13362.88 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 40977.57 | 803 / 803 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.08 | 1 / 1 |
adipose | 100% | 7864.83 | 1202 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 13.06 | 44 / 45 |
pancreas | 3% | 84.41 | 9 / 328 | 95% | 12.12 | 169 / 178 |
brain | 7% | 253.15 | 197 / 2642 | 88% | 7.81 | 618 / 705 |
heart | 94% | 17435.31 | 812 / 861 | 0% | 0 | 0 / 0 |
kidney | 6% | 220.27 | 5 / 89 | 88% | 11.48 | 791 / 901 |
lymph node | 0% | 0 | 0 / 0 | 76% | 6.39 | 22 / 29 |
eye | 0% | 0 | 0 / 0 | 39% | 2.15 | 31 / 80 |
peripheral blood | 11% | 394.13 | 104 / 929 | 0% | 0 | 0 / 0 |
spleen | 5% | 150.65 | 11 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007254 | Biological process | JNK cascade |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0030071 | Biological process | regulation of mitotic metaphase/anaphase transition |
GO_0006954 | Biological process | inflammatory response |
GO_0000165 | Biological process | MAPK cascade |
GO_0007059 | Biological process | chromosome segregation |
GO_0008219 | Biological process | cell death |
GO_0060173 | Biological process | limb development |
GO_0042733 | Biological process | embryonic digit morphogenesis |
GO_0070269 | Biological process | pyroptotic inflammatory response |
GO_0007010 | Biological process | cytoskeleton organization |
GO_1904291 | Biological process | positive regulation of mitotic DNA damage checkpoint |
GO_0071480 | Biological process | cellular response to gamma radiation |
GO_0071493 | Biological process | cellular response to UV-B |
GO_0051403 | Biological process | stress-activated MAPK cascade |
GO_0043068 | Biological process | positive regulation of programmed cell death |
GO_0030154 | Biological process | cell differentiation |
GO_0140469 | Biological process | GCN2-mediated signaling |
GO_0031098 | Biological process | stress-activated protein kinase signaling cascade |
GO_0006468 | Biological process | protein phosphorylation |
GO_0038066 | Biological process | p38MAPK cascade |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0000077 | Biological process | DNA damage checkpoint signaling |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0043022 | Molecular function | ribosome binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0004709 | Molecular function | MAP kinase kinase kinase activity |
GO_0030295 | Molecular function | protein kinase activator activity |
GO_0004706 | Molecular function | JUN kinase kinase kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0003723 | Molecular function | RNA binding |
GO_0070181 | Molecular function | small ribosomal subunit rRNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | MAP3K20 |
Protein name | Mitogen-activated protein kinase kinase kinase 20 (EC 2.7.11.25) (Human cervical cancer suppressor gene 4 protein) (HCCS-4) (Leucine zipper- and sterile alpha motif-containing kinase) (MLK-like mitogen-activated protein triple kinase) (Mitogen-activated protein kinase kinase kinase MLT) (Mixed lineage kinase 7) (Mixed lineage kinase-related kinase) (MLK-related kinase) (MRK) (Sterile alpha motif- and leucine zipper-containing kinase AZK) Mitogen-activated protein kinase kinase kinase 20 |
Synonyms | ZAK MLK7 MLTK HCCS4 |
Description | FUNCTION: Stress-activated component of a protein kinase signal transduction cascade that promotes programmed cell death in response to various stress, such as ribosomal stress, osmotic shock and ionizing radiation . Acts by catalyzing phosphorylation of MAP kinase kinases, leading to activation of the JNK (MAPK8/JNK1, MAPK9/JNK2 and/or MAPK10/JNK3) and MAP kinase p38 (MAPK11, MAPK12, MAPK13 and/or MAPK14) pathways . Activates JNK through phosphorylation of MAP2K4/MKK4 and MAP2K7/MKK7, and MAP kinase p38 gamma (MAPK12) via phosphorylation of MAP2K3/MKK3 and MAP2K6/MKK6 . Involved in stress associated with adrenergic stimulation: contributes to cardiac decompensation during periods of acute cardiac stress . May be involved in regulation of S and G2 cell cycle checkpoint by mediating phosphorylation of CHEK2 . .; FUNCTION: [Isoform ZAKalpha]: Key component of the stress-activated protein kinase signaling cascade in response to ribotoxic stress or UV-B irradiation . Acts as the proximal sensor of ribosome collisions during the ribotoxic stress response (RSR): directly binds to the ribosome by inserting its flexible C-terminus into the ribosomal intersubunit space, thereby acting as a sentinel for colliding ribosomes . Upon ribosome collisions, activates either the stress-activated protein kinase signal transduction cascade or the integrated stress response (ISR), leading to programmed cell death or cell survival, respectively . Dangerous levels of ribosome collisions trigger the autophosphorylation and activation of MAP3K20, which dissociates from colliding ribosomes and phosphorylates MAP kinase kinases, leading to activation of the JNK and MAP kinase p38 pathways that promote programmed cell death . Less dangerous levels of ribosome collisions trigger the integrated stress response (ISR): MAP3K20 activates EIF2AK4/GCN2 independently of its protein-kinase activity, promoting EIF2AK4/GCN2-mediated phosphorylation of EIF2S1/eIF-2-alpha . Also part of the stress-activated protein kinase signaling cascade triggering the NLRP1 inflammasome in response to UV-B irradiation: ribosome collisions activate MAP3K20, which directly phosphorylates NLRP1, leading to activation of the NLRP1 inflammasome and subsequent pyroptosis . NLRP1 is also phosphorylated by MAP kinase p38 downstream of MAP3K20 . Also acts as a histone kinase by phosphorylating histone H3 at 'Ser-28' (H3S28ph) . .; FUNCTION: [Isoform ZAKbeta]: Isoform that lacks the C-terminal region that mediates ribosome-binding: does not act as a sensor of ribosome collisions in response to ribotoxic stress . May act as an antagonist of isoform ZAKalpha: interacts with isoform ZAKalpha, leading to decrease the expression of isoform ZAKalpha . . |
Accessions | C9J3F7 Q9NYL2 ENST00000422149.1 ENST00000338983.7 [Q9NYL2-2] ENST00000539448.5 [Q9NYL2-2] ENST00000409176.6 [Q9NYL2-1] ENST00000375213.8 [Q9NYL2-1] |